Advertisement

Ads Placeholder
Loading...

Kinarus Therapeutics Holding AG

PRFN.SWSIX
Industrials
Airlines, Airports & Air Services
CHF0.04
CHF-0.00(-8.12%)
Swiss Market opens in 45h 56m

Kinarus Therapeutics Holding AG (PRFN.SW) AI-Powered Stock Analysis

See how Kinarus Therapeutics Holding AG scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Kinarus Therapeutics Holding AG (PRFN.SW) Stock Overall Grade

Kinarus Therapeutics Holding AG’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

Z

Grade Breakdown by Metric

See how each financial and market factor contributes to Kinarus Therapeutics Holding AG's overall stock rating.

Forecast

C+

Score

50/100

Financial Growth

C

Score

40/100

Fundamental Growth

C+

Score

50/100

Key Ratios

C+

Score

57/100

Sector Comparison

B+

Score

75/100

Industry Comparison

C+

Score

50/100

S&P 500 Benchmark

A+

Score

96/100

Analyst Consensus

C+

Score

50/100

Kinarus Therapeutics Holding AG (PRFN.SW) AI-Powered Stock Analysis

This asset demonstrates Normal performance with an overall Forecast Score of 50/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (57/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.

Component Analysis Explained

Understand the key factors behind each Kinarus Therapeutics Holding AG stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions